Trial Profile
A Study Evaluating Clonal Dynamics Of Refractory Aplastic Anemia In Patients Treated With Eltrombopag.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Feb 2017
Price :
$35
*
At a glance
- Drugs Eltrombopag (Primary)
- Indications Aplastic anaemia
- Focus Pharmacodynamics; Therapeutic Use
- 06 Feb 2017 New trial record